Pediatric Nephrology

, Volume 25, Issue 2, pp 267–274

Ibuprofen in very preterm infants impairs renal function for the first month of life

  • Rachel Vieux
  • Roxane Desandes
  • Farid Boubred
  • Denis Semama
  • Francis Guillemin
  • Marie-Christine Buchweiller
  • Jeanne Fresson
  • Jean-Michel Hascoet
Original Article


We carried out a study aiming to determine the renal effect of ibuprofen treatment for patent ductus arteriosus (PDA) in very preterm infants during the first month of life. Infants aged 27−31 weeks gestation were enrolled from October 2004 to August 2006. They were assigned to two different groups according to ibuprofen exposure during care of their PDA status assessed by echocardiography. Infants of both groups were matched based on gestational age, Clinical Risk Index for Babies score, birth weight and inclusion center. Renal function was evaluated at baseline and weekly for 1 month. One hundred and forty-eight infants were enrolled. Glomerular filtration rate (GFR) was significantly decreased in the ibuprofen group after treatment withdrawal (GFR on day 7, ibuprofen versus no ibuprofen: 12.8 ± 6.2 vs. 18.1 ± 12.1 ml/min/1.73 m2; P < 0.001). Adjusted analysis proved this decrease to be sustained during the first month of life. Tubular function was also impaired during the first month in ibuprofen-treated infants. Ibuprofen administered for PDA is associated with a decreased GFR during the first month of life. Renal function of infants receiving ibuprofen should be carefully monitored and drugs that are eliminated by glomerular filtration handled cautiously during this period.


Ibuprofen Renal impairment Very low birth weight Patent ductus arteriosus Neonates 


  1. 1.
    Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE (1976) Pharmacologic closure of patent ductus arteriosus in the premature infant. N Engl J Med 295:526–529PubMedGoogle Scholar
  2. 2.
    Heymann MA, Rudolph AM, Silverman NH (1976) Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 295:530–533PubMedGoogle Scholar
  3. 3.
    Gersony M, Peckham J, Curtis Ellison R, Miettinen S, Nadas S (1983) Effects of Indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study. J Pediatr 102:895–906CrossRefPubMedGoogle Scholar
  4. 4.
    Danilowicz D, Rudolph AM, Hoffman JI (1966) Delayed closure of the ductus arteriosus in premature infants. Pediatrics 37:74–78PubMedGoogle Scholar
  5. 5.
    Krovetz LJ, Rowe RD (1972) Patent ductus, prematurity and pulmonary disease. N Engl J Med 287:513–514PubMedCrossRefGoogle Scholar
  6. 6.
    Brown ER (1979) Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 95:865–866CrossRefPubMedGoogle Scholar
  7. 7.
    Van Overmeire B, Follens I, Hartmann S, Creten W, Van Acker KJ (1997) Treatment of patent ductus arteriosus with Ibuprofen. Arch Dis Child 76:F179–F184Google Scholar
  8. 8.
    Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries JP (2000) A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 343:674–681CrossRefPubMedGoogle Scholar
  9. 9.
    Dani C, Bertini G, Pezzati M, Poggi C, Guerrini P, Martano C, Rubaltelli FF, Intraventricular Ibuprofen Study Group (2005) Prophylactic ibuprofen for the prevention of IVH among preterm infants: a multicenter, randomized study. Pediatrics 115:1529–1535CrossRefPubMedGoogle Scholar
  10. 10.
    Iacobelli S, Bonsante F, Ferdinus C, Labenne M, Gouyon JB (2009) Factors affecting postnatal changes in serum creatinine in preterm infants with gestational age <32 weeks. J Perinatol 29:232–236CrossRefPubMedGoogle Scholar
  11. 11.
    Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli R (1999) Effects of Indomethacin and Ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 135:733–738CrossRefPubMedGoogle Scholar
  12. 12.
    Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L (2006) Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 21:931–938CrossRefPubMedGoogle Scholar
  13. 13.
    Gournay V, Roze JC, Kuster A, Daoud P, Cambonie G, Hascoet JM, Chamboux C, Blanc T, Fichtner C, Savagner C, Gouyon JB, Flurin V, Thiriez G (2004) Multicentric prospective randomized double blind trial comparing prophylactic ibuprofen versus curative ibuprofen in very premature infants less than 28 weeks of gestation. Lancet 364:1939–1944CrossRefPubMedGoogle Scholar
  14. 14.
    Allegaert K, Rayyan M, Anderson BJ (2006) Impact of ibuprofen administration on renal drug clearance in the first weeks of life. Methods Find Exp Clin Pharmacol 28:519–522CrossRefPubMedGoogle Scholar
  15. 15.
    Ohlsson A, Walia R, Shah S (2008) Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (1):CD003481Google Scholar
  16. 16.
    Antonucci R, Cuzzolin L, Arceri A, Dessi A, Fanos V (2009) Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductis arteriosus. Eur J Clin Pharmacol 65:223–230CrossRefPubMedGoogle Scholar
  17. 17.
    Aranda JV, Clyman R, Cox B, Van Overmeire B, Wozniak P, Sosenko I, Carlo WA, Ward RM, Shalwitz R, Baggs G, Seth A, Darko L (2009) A randomized, double-blind, placebo-controlled trial on IV ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol 26:235–245CrossRefPubMedGoogle Scholar
  18. 18.
    Bueva A, Guignard JP (1994) Renal function in preterm neonates. Pediatr Res 36:572–577PubMedGoogle Scholar
  19. 19.
    Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127:774–779CrossRefPubMedGoogle Scholar
  20. 20.
    Su BH, Watanabe T, Shimizu M, Yanagisawa M (1997) Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child Fetal Neonatal Ed 77:F36–F40CrossRefPubMedGoogle Scholar
  21. 21.
    El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L (2005) Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 90:F419–F422CrossRefPubMedGoogle Scholar
  22. 22.
    Desfrere L, Zohar S, Morville P, Brunhes A, Chevret S, Pons G, Moriette G, Rey E, Treluyer JM (2003) Dose-finding study of Ibuprofen in patent ductus arteriosus. Biol Neonate 84:272Google Scholar
  23. 23.
    The International Neonatal Network (1993) The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 342:193–198CrossRefGoogle Scholar
  24. 24.
    Schwartz GJ, Brion LP, Spitzer A (1987) The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 34:571–590PubMedGoogle Scholar
  25. 25.
    Ojala R, Ala-Houhala M, Harmoinen AP, Luukkaala T, Uotila T, Tammela O (2006) Tubular proteinuria in pre-term and full-term infants. Pediatr Nephrol 21:68–73CrossRefPubMedGoogle Scholar
  26. 26.
    Guignard JP, Drukker A (1999) Why do newborn infants have a high plasma creatinine? Pediatrics 103:e49CrossRefPubMedGoogle Scholar
  27. 27.
    Guignard JP (1982) Renal function in the newborn infant. Pediatr Clin North Am 29:777–790PubMedGoogle Scholar
  28. 28.
    Van Overmeire B, Allegaert K, Casaer A, Debauche C, Decaluwé W, Jespers A, Weyler J, Harrewijn I, Langhendries JP (2004) Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 364:1945–1949CrossRefPubMedGoogle Scholar
  29. 29.
    Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia OS (2002) Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 161:202–207CrossRefPubMedGoogle Scholar
  30. 30.
    Deschaux M (1994) Explorations fonctionnelles rénales chez l’enfant. Editions techniques, Encycl Med Chir, Pediatrie 4-083-J-10, 4pGoogle Scholar
  31. 31.
    Koch J, Hensley G, Roy L, Brown S, Ramaciotti C, Rosenfeld CR (2006) Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 117:1113–1121CrossRefPubMedGoogle Scholar
  32. 32.
    Guignard JP, Mattheova E (2002) Postnatal adaptation of the kidney. ESPN Handbook, Medcom, Lyon, France, pp 37–43Google Scholar
  33. 33.
    Kempley ST, Gamsu HR, Nicolaides KH (1993) Renal artery blood flow velocity in very low birthweight infants with intrauterine growth retardation. Arch Dis Child 68:588–590CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2009

Authors and Affiliations

  • Rachel Vieux
    • 1
    • 2
    • 6
  • Roxane Desandes
    • 1
  • Farid Boubred
    • 3
  • Denis Semama
    • 4
  • Francis Guillemin
    • 2
  • Marie-Christine Buchweiller
    • 1
  • Jeanne Fresson
    • 5
  • Jean-Michel Hascoet
    • 1
  1. 1.Maternite Regionale, Neonatal DepartmentNancy-UniversityNancyFrance
  2. 2.INSERM, CIC-EC, CHU de Nancy, Nancy-UniversityNancyFrance
  3. 3.Neonatal DepartmentAP-HM, La Conception HospitalMarseilleFrance
  4. 4.Neonatal DepartmentCHU Le BocageDijonFrance
  5. 5.Maternite Regionale, Clinical Epidemiology and Biostatistics DepartmentNancy-UniversityNancyFrance
  6. 6.Department of NeonatologyMaternite Regionale UniversitaireNancyFrance

Personalised recommendations